Register entry
Pfizer Laboratories Div Pfizer Inc
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 240
- Labeller names
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
240240 active NDC listings: 203 human prescription drug, 27 plasma derivative, 8 vaccine, 2 drug for further processing. By marketing category: NDA 157, BLA 77, ANDA 3, DRUG FOR FURTHER PROCESSING 2, UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE 1.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 43 |
| injection, solution | 37 |
| kit | 27 |
| solution | 25 |
| tablet | 24 |
| capsule | 19 |
| injection | 12 |
| injection, suspension | 10 |
| capsule, liquid filled | 8 |
| injection, powder, lyophilized, for solution | 6 |
| tablet, film coated, extended release | 6 |
| capsule, coated pellets | 3 |
| injection, emulsion | 3 |
| powder, for suspension | 3 |
| capsule, extended release | 2 |
| Route | NDCs |
|---|---|
| oral | 112 |
| intravenous | 54 |
| subcutaneous | 35 |
| intramuscular | 16 |
| topical | 4 |
| nasal | 2 |
| vaginal | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| pfizer laboratories div pfizer inc | 233 |
| pfizer laboratories div pfizer inc | 7 |
Catalogue
Marketed products
241Showing 150 of 241.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| ABRILADA | adalimumab-afzb | kit | 0025-0325BLA |
| ABRILADA | adalimumab-afzb | kit | 0025-0328BLA |
| ABRILADA | adalimumab-afzb | kit | 0025-0333BLA |
| ARTHROTEC | diclofenac sodium and misoprostol | tablet, film coated, oral | 0025-1411NDA |
| ARTHROTEC | diclofenac sodium and misoprostol | tablet, film coated, oral | 0025-1421NDA |
| Abrysvo | Respiratory Syncytial Virus Vaccine | injection, powder, lyophilized, for solution, intramuscular | 0069-2465BLA |
| Aldactone | spironolactone | tablet, film coated, oral | 0025-1001NDA |
| Aldactone | spironolactone | tablet, film coated, oral | 0025-1031NDA |
| Aldactone | spironolactone | tablet, film coated, oral | 0025-1041NDA |
| Azulfidine | Sulfasalazine | tablet, oral | 0013-0101NDA |
| Azulfidine EN-tabs | Sulfasalazine | tablet, delayed release, oral | 0013-0102NDA |
| BICILLIN C-R 900/300 | penicillin G benzathine and penicillin G procaine | injection, suspension, intramuscular | 60793-602NDA |
| BICILLIN CR | penicillin G benzathine and penicillin G procaine | injection, suspension, intramuscular | 60793-600NDA |
| BICILLIN CR | penicillin G benzathine and penicillin G procaine | injection, suspension, intramuscular | 60793-601NDA |
| BICILLIN L-A | penicillin G benzathine | injection, suspension, intramuscular | 60793-700NDA |
| BICILLIN L-A | penicillin G benzathine | injection, suspension, intramuscular | 60793-701NDA |
| BICILLIN L-A | penicillin G benzathine | injection, suspension, intramuscular | 60793-702NDA |
| BOSULIF | Bosutinib | tablet, film coated, oral | 0069-0135NDA |
| BOSULIF | Bosutinib | tablet, film coated, oral | 0069-0136NDA |
| BOSULIF | Bosutinib | tablet, film coated, oral | 0069-0193NDA |
| BOSULIF | Bosutinib | capsule, oral | 0069-0504NDA |
| BOSULIF | Bosutinib | capsule, oral | 0069-1014NDA |
| CEREBYX | Fosphenytoin Sodium | injection, solution, intramuscular, intravenous | 0069-5471NDA |
| CEREBYX | Fosphenytoin Sodium | injection, solution, intramuscular, intravenous | 0069-5474NDA |
| CEREBYX | Fosphenytoin Sodium | injection, solution, intramuscular, intravenous | 0069-6001NDA |
| CHANTIX | varenicline tartrate | tablet, film coated, oral | 0069-0468NDA |
| CHANTIX | varenicline tartrate | tablet, film coated, oral | 0069-0469NDA |
| CHANTIX | varenicline tartrate | kit | 0069-0471NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-6180NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-6323NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-6565NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-6747NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-7232NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-7476NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-7654NDA |
| Caduet | amlodipine and atorvastatin | tablet, film coated, oral | 0069-7810NDA |
| Cibinqo | abrocitinib | tablet, film coated, oral | 0069-0235NDA |
| Cibinqo | abrocitinib | tablet, film coated, oral | 0069-0335NDA |
| Cibinqo | abrocitinib | tablet, film coated, oral | 0069-0435NDA |
| Comirnaty | COVID-19 Vaccine, mRNA | injection, suspension, intramuscular | 0069-2501BLA |
| Comirnaty | COVID-19 Vaccine, mRNA | injection, suspension, intramuscular | 0069-2528BLA |
| Comirnaty | COVID-19 Vaccine, mRNA | injection, suspension, intramuscular | 0069-2609BLA |
| Comirnaty | COVID-19 Vaccine, mRNA | injection, suspension, intramuscular | 0069-2631BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1061BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1476BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1509BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1802BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1960BLA |
| Cutaquig | immunoglobulin G | solution, subcutaneous | 0069-1965BLA |
| Cyklokapron | tranexamic acid | injection, solution, intravenous | 0013-1114NDA |
| Cytomel | liothyronine sodium | tablet, oral | 60793-115NDA |
| Cytomel | liothyronine sodium | tablet, oral | 60793-116NDA |
| Cytomel | liothyronine sodium | tablet, oral | 60793-117NDA |
| Cytotec | misoprostol | tablet, oral | 0025-1451NDA |
| Cytotec | misoprostol | tablet, oral | 0025-1461NDA |
| Daurismo | glasdegib | tablet, film coated, oral | 0069-0298NDA |
| Daurismo | glasdegib | tablet, film coated, oral | 0069-1531NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-0255NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-0277NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-0343NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-0358NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-1442NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-1542NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-3358NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-4031NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-4205NDA |
| Doxorubicin Hydrochloride | Doxorubicin Hydrochloride | injection, solution, intravenous | 0069-5629NDA |
| ELELYSO | Taliglucerase alfa | injection, powder, lyophilized, for solution, intravenous | 0069-0106BLA |
| Elrexfio | elranatamab-bcmm | injection, solution, subcutaneous | 0069-2522BLA |
| Elrexfio | elranatamab-bcmm | injection, solution, subcutaneous | 0069-4494BLA |
| Estring | estradiol | system, vaginal | 0013-1042NDA |
| Eucrisa | crisaborole | ointment, topical | 55724-211NDA |
| Flagyl | metronidazole | capsule, oral | 0025-1942NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0195NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0196NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0206NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0217NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0220NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0223NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0228NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0232NDA |
| Fragmin | Dalteparin Sodium | injection, subcutaneous | 0069-0253NDA |
| GENOTROPIN | somatropin | kit | 0013-2626BLA |
| GENOTROPIN | somatropin | kit | 0013-2646BLA |
| GENOTROPIN | somatropin | kit | 0013-2649BLA |
| GENOTROPIN | somatropin | kit | 0013-2650BLA |
| GENOTROPIN | somatropin | kit | 0013-2651BLA |
| GENOTROPIN | somatropin | kit | 0013-2652BLA |
| GENOTROPIN | somatropin | kit | 0013-2653BLA |
| GENOTROPIN | somatropin | kit | 0013-2654BLA |
| GENOTROPIN | somatropin | kit | 0013-2655BLA |
| GENOTROPIN | somatropin | kit | 0013-2656BLA |
| GENOTROPIN | somatropin | kit | 0013-2657BLA |
| GENOTROPIN | somatropin | kit | 0013-2658BLA |
| HYMPAVZI | marstacimab-hncq | injection, solution, subcutaneous | 0069-0775BLA |
| HYMPAVZI | marstacimab-hncq | injection, solution, subcutaneous | 0069-1510BLA |
| HYMPAVZI | marstacimab-hncq | injection, solution, subcutaneous | 0069-2151BLA |
| Heparin Sodium | Heparin Sodium | injection, intravenous, subcutaneous | 0069-0043NDA |
| INFLECTRA | infliximab-dyyb | injection, powder, lyophilized, for solution, intravenous | 0069-0809BLA |
| INLYTA | axitinib | tablet, film coated, oral | 0069-0145NDA |
| INLYTA | axitinib | tablet, film coated, oral | 0069-0151NDA |
| Ibrance | palbociclib | capsule, oral | 0069-0187NDA |
| Ibrance | palbociclib | capsule, oral | 0069-0188NDA |
| Ibrance | palbociclib | capsule, oral | 0069-0189NDA |
| Ibrance | palbociclib | tablet, film coated, oral | 0069-0284NDA |
| Ibrance | palbociclib | tablet, film coated, oral | 0069-0486NDA |
| Ibrance | palbociclib | tablet, film coated, oral | 0069-0688NDA |
| Idamycin PFS | idarubicin hydrochloride | solution, intravenous | 0013-2576NDA |
| Idamycin PFS | idarubicin hydrochloride | solution, intravenous | 0013-2586NDA |
| Idamycin PFS | idarubicin hydrochloride | solution, intravenous | 0013-2596NDA |
| LEDERLE LEUCOVORIN | calcium folinate | tablet, oral | 0069-5886UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-850NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-851NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-852NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-853NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-854NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-855NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-856NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-857NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-858NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-859NDA |
| LEVOXYL | levothyroxine sodium | tablet, oral | 60793-860NDA |
| Litfulo | ritlecitinib | capsule, oral | 0069-0334NDA |
| Lomotil | diphenoxylate hydrochloride and atropine sulfate | tablet, oral | 0025-0061NDA |
| Lorbrena | lorlatinib | tablet, film coated, oral | 0069-0227NDA |
| Lorbrena | lorlatinib | tablet, film coated, oral | 0069-0231NDA |
| NURTEC ODT | rimegepant sulfate | tablet, orally disintegrating, oral | 72618-3000NDA |
| NURTEC ODT | rimegepant sulfate | tablet, orally disintegrating, oral | 72618-3001NDA |
| NYVEPRIA | pegfilgrastim-apgf | injection, solution, subcutaneous | 0069-0324BLA |
| Ngenla | somatrogon-ghla | injection, solution, subcutaneous | 0069-0505BLA |
| Ngenla | somatrogon-ghla | injection, solution, subcutaneous | 0069-0520BLA |
| Nivestym | filgrastim-aafi | injection, solution, subcutaneous | 0069-0291BLA |
| Nivestym | filgrastim-aafi | injection, solution, subcutaneous | 0069-0292BLA |
| Nivestym | filgrastim-aafi | injection, solution, intravenous, subcutaneous | 0069-0293BLA |
| Nivestym | filgrastim-aafi | injection, solution, intravenous, subcutaneous | 0069-0294BLA |
| Norpace | disopyramide phosphate | capsule, gelatin coated, oral | 0025-2752NDA |
| Norpace | disopyramide phosphate | capsule, gelatin coated, oral | 0025-2762NDA |
| Norpace CR | disopyramide phosphate | capsule, extended release, oral | 0025-2732NDA |
| Norpace CR | disopyramide phosphate | capsule, extended release, oral | 0025-2742NDA |
| Norvasc | amlodipine besylate | tablet, oral | 0069-1520NDA |
| Norvasc | amlodipine besylate | tablet, oral | 0069-1530NDA |
| Norvasc | amlodipine besylate | tablet, oral | 0069-1540NDA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-6002BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-6111BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-6237BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-6339BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-6550BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-8400BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-8425BLA |
| Octagam Immune Globulin (Human) | Immune Globulin | solution, intravenous | 0069-8451BLA |
Compare
Other companies listing somatropin
- Novartis Pharmaceuticals Corporation20 sites · 210 NDC
- EMD Serono, Inc.12 sites · 18 NDC
- Novo Nordisk Inc.11 sites · 124 NDC
- Ferring Pharmaceuticals Inc.9 sites · 17 NDC
- Genentech, Inc.8 sites · 93 NDC
- Hefei Xinzhu Biological Technology Co Ltd.1 site · 5 NDC
Enquiry
Common questions
- Is Pfizer Laboratories Div Pfizer Inc FDA approved?
- Pfizer Laboratories Div Pfizer Inc holds no registered establishment of its own; 241 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Pfizer Laboratories Div Pfizer Inc make?
- 241 products are listed under Pfizer Laboratories Div Pfizer Inc in the openFDA NDC Directory, most often as tablet, film coated; injection, solution; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.